ArticleFrontiers in immunology2012

Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.

Mark D Mannie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.